Morgan Stanley’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.83K | Sell |
1,915
-3,508
| -65% | -$14.3K | ﹤0.01% | 6921 |
|
|
2025
Q1 | $9.33K | Hold |
5,423
| – | – | ﹤0.01% | 6823 |
|
|
2024
Q4 | $7.97K | Hold |
5,423
| – | – | ﹤0.01% | 6880 |
|
|
2024
Q3 | $9.27K | Hold |
5,423
| – | – | ﹤0.01% | 6739 |
|
|
2024
Q2 | $11.4K | Hold |
5,423
| – | – | ﹤0.01% | 6630 |
|
|
2024
Q1 | $11.9K | Sell |
5,423
-62,125
| -92% | -$136K | ﹤0.01% | 6648 |
|
|
2023
Q4 | $234K | Buy |
67,548
+52,256
| +342% | +$181K | ﹤0.01% | 5884 |
|
|
2023
Q3 | $22.6K | Hold |
15,292
| – | – | ﹤0.01% | 6440 |
|
|
2023
Q2 | $23.7K | Hold |
15,292
| – | – | ﹤0.01% | 6512 |
|
|
2023
Q1 | $16.4K | Hold |
15,292
| – | – | ﹤0.01% | 6695 |
|
|
2022
Q4 | $17.7K | Hold |
15,292
| – | – | ﹤0.01% | 6733 |
|
|
2022
Q3 | $14K | Sell |
15,292
-2,962
| -16% | -$2.71K | ﹤0.01% | 6953 |
|
|
2022
Q2 | $28K | Buy |
18,254
+10,729
| +143% | +$16.5K | ﹤0.01% | 6854 |
|
|
2022
Q1 | $33K | Buy |
7,525
+1,049
| +16% | +$4.6K | ﹤0.01% | 6902 |
|
|
2021
Q4 | $38K | Sell |
6,476
-7,361
| -53% | -$43.2K | ﹤0.01% | 6933 |
|
|
2021
Q3 | $121K | Buy |
13,837
+9,004
| +186% | +$78.7K | ﹤0.01% | 6264 |
|
|
2021
Q2 | $49K | Buy |
4,833
+1,018
| +27% | +$10.3K | ﹤0.01% | 6685 |
|
|
2021
Q1 | $25K | Hold |
3,815
| – | – | ﹤0.01% | 6646 |
|
|
2020
Q4 | $33K | Hold |
3,815
| – | – | ﹤0.01% | 6289 |
|
|
2020
Q3 | $28K | Hold |
3,815
| – | – | ﹤0.01% | 5935 |
|
|
2020
Q2 | $32K | Hold |
3,815
| – | – | ﹤0.01% | 5849 |
|
|
2020
Q1 | $24K | Buy |
+3,815
| New | +$24K | ﹤0.01% | 5743 |
|